All Stories

  1. Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries

    Article • September 2021, European Respiratory Society (ERS)

    Martina Vasakova

  2. Long-term overall survival and progression-free survival in idiopathic pulmonary fibrosis treated by pirfenidone or nintedanib or their switch. Real world data from the EMPIRE registry

    Article • September 2019, European Respiratory Society (ERS)

    Martina Vasakova

  3. Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment

    Article • American Journal of Respiratory and Critical Care Medicine, August 2019, American Thoracic Society

    Martina Vasakova

  4. Fibroproliferative

    Article • The Open Respiratory Medicine Journal, December 2012, Bentham Science Publishers

    Martina Vasakova